Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 76 to 90 of 129 results for urinary incontinence

  1. Laparoscopic ventral mesh rectopexy for internal rectal prolapse (HTG475)

    Evidence-based recommendations on laparoscopic ventral mesh rectopexy for internal rectal prolapse in adults. This involves using a piece of sterile material (mesh) to attach the rectum to the lower back bone using keyhole surgery.

    HealthTech guidance
    Published
    20 June 2018
    View recommendations

    Sections for HTG475

  2. Transient loss of consciousness ('blackouts') in over 16s (CG109)

    This guideline covers assessment, diagnosis and referral for people over 16 who have had a transient loss of consciousness (TLoC; also called a blackout). It aims to improve care for people with TLoC by specifying the most effective assessments and recommending when to refer to a specialist.

    Clinical guideline
    Last updated
    21 November 2023
    View recommendations

    Sections for CG109

  3. Autism spectrum disorder in under 19s: recognition, referral and diagnosis (CG128)

    This guideline covers recognising and diagnosing autism spectrum disorder in children and young people from birth up to 19 years. It also covers referral. It aims to improve the experience of children, young people and those who care for them.

    Clinical guideline
    Last updated
    20 December 2017
    View recommendations

    Sections for CG128

  4. Low dose rate brachytherapy for localised prostate cancer (HTG81)

    Evidence-based recommendations on low dose rate brachytherapy for localised prostate cancer. This involves placing small radioactive seeds into the prostate that give off low doses of radiation to destroy cancer cells.

    HealthTech guidance
    Published
    27 July 2005
    View recommendations

    Sections for HTG81

  5. Transvaginal laser therapy for urogenital atrophy (HTG582)

    Evidence-based recommendations on transvaginal laser therapy for urogenital atrophy. This involves using a laser in the vagina to increase its strength and elasticity, to improve symptoms of urogenital atrophy.

    HealthTech guidance
    Published
    26 May 2021
    View recommendations

    Sections for HTG582

  6. Stage 4: treatment, assessment and monitoring

    In virtual wards, people can receive virtual and technology-assisted treatment, assessment, and monitoring.

  7. What is the safety and efficacy of botulinum toxin compared with (a) usual care, (b) antimuscarinics and (c) augmentation cystoplasty in people with primary cerebral conditions with lower urinary tract dysfunction?

    augmentation cystoplasty in people with primary cerebral conditions with lower urinary tract dysfunction? Any explanatory notes(if...

    Research recommendation
    Published
    9 June 2015

  8. Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia (HTG545)

    Evidence-based recommendations on Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia.

    HealthTech guidance
    Published
    24 June 2020
    View recommendations

    Sections for HTG545

  9. What is the effectiveness and safety of anticholinergic medicines for overactive bladder in older women?

    Source guidance details Comes from guidance Urinary incontinence and pelvic organ prolapse in women: management Number

    Research recommendation
    Published
    21 June 2019

  10. What is the effectiveness of colpocleisis compared with sacrospinous fixation for pelvic organ prolapse in elderly women?

    Source guidance details Comes from guidance Urinary incontinence and pelvic organ prolapse in women: management Number

    Research recommendation
    Published
    21 June 2019

  11. What is the long-term effectiveness of bladder wall injection with botulinum toxin type A for overactive bladder in women?

    Source guidance details Comes from guidance Urinary incontinence and pelvic organ prolapse in women: management Number

    Research recommendation
    Published
    21 June 2019

  12. What are the long-term outcomes, including patient satisfaction, from the use of pessaries compared with surgery for pelvic organ prolapse in women?

    Source guidance details Comes from guidance Urinary incontinence and pelvic organ prolapse in women: management Number

    Research recommendation
    Published
    21 June 2019

  13. Focal therapy using high-intensity focused ultrasound for localised prostate cancer (HTG667)

    Evidence-based recommendations on focal therapy using high-intensity focused ultrasound for localised prostate cancer. This involves using high-intensity focused ultrasound to heat up and destroy only the areas of the prostate with cancer (focal therapy). The aim is to destroy the cancer while reducing damage to healthy prostate tissue.

    HealthTech guidance
    Published
    5 April 2023
    View recommendations

    Sections for HTG667

  14. Safety and efficacy of antimuscarinics:- What is the safety and efficacy of more recently developed antimuscarinics compared with (a) placebo/usual care and (b) other antimuscarinics in the treatment of neurogenic lower urinary tract dysfunction?

    care and (b) other antimuscarinics in the treatment of neurogenic lower urinary tract dysfunction? Any explanatory notes(if applicable)...

    Research recommendation
    Published
    9 June 2015

  15. Bladder management strategies:- What are the long-term risks and effects on quality of life of different bladder management strategies for lower urinary tract dysfunction in people with neurological disease?

    on quality of life of different bladder management strategies for lower urinary tract dysfunction in people with neurological disease?...

    Research recommendation
    Published
    9 June 2015